Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Non-Current Debt: 2022-2024

  • Universe Pharmaceuticals' Non-Current Debt was N/A to $2.1 million in Q3 2024 from the same period last year, while for Sep 2024 it was $2.1 million, marking a year-over-year change of. This contributed to the annual value of $2.1 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Universe Pharmaceuticals reported Non-Current Debt of $2.1 million as of Q3 2024, which was up 2.89% from $2.1 million recorded in Q1 2024.
  • In the past 5 years, Universe Pharmaceuticals' Non-Current Debt registered a high of $166,666.7 billion during Q3 2022, and its lowest value of $100,000.0 billion during Q1 2022.
  • Over the past 1 years, Universe Pharmaceuticals' median Non-Current Debt value was $2.1 million (recorded in 2024), while the average stood at $2.1 million.
  • Data for Universe Pharmaceuticals' Non-Current Debt shows a peak YoY soared of 66.67% (in 2023) over the last 5 years.
  • Quarterly analysis of 2 years shows Universe Pharmaceuticals' Non-Current Debt stood at $166,666.7 billion in 2022, then skyrocketed by 66.67% to $166,666.7 billion in 2023.
  • Its Non-Current Debt was $166,666.7 billion in Q1 2023, compared to $166,666.7 billion in Q3 2022 and $100,000.0 billion in Q1 2022.